Kathleen Jaeger of America's Generic Pharmaceutical Association adds that branded firms try to extend their lucrative monopolies by filing less rigorous secondary patents designed “to block generics”.
美国通用药物协会的Kathleen Jaeger补充说很多品牌药公司制作大量的文件申请专利分案“以阻碍仿制药”。
Kathleen Jaeger of America's Generic Pharmaceutical Association adds that branded firms try to extend their lucrative monopolies by filing less rigorous secondary patents designed “to block generics”.
美国通用药物协会的Kathleen Jaeger补充说很多品牌药公司制作大量的文件申请专利分案“以阻碍仿制药”。
应用推荐